These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 26167252)
1. Non-alcohol fatty liver disease in Asia: Prevention and planning. Ashtari S; Pourhoseingholi MA; Zali MR World J Hepatol; 2015 Jul; 7(13):1788-96. PubMed ID: 26167252 [TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma in Asia: Prevention strategy and planning. Ashtari S; Pourhoseingholi MA; Sharifian A; Zali MR World J Hepatol; 2015 Jun; 7(12):1708-17. PubMed ID: 26140091 [TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. Chitturi S; Farrell GC; Hashimoto E; Saibara T; Lau GK; Sollano JD; J Gastroenterol Hepatol; 2007 Jun; 22(6):778-87. PubMed ID: 17565630 [TBL] [Abstract][Full Text] [Related]
4. New trends on obesity and NAFLD in Asia. Fan JG; Kim SU; Wong VW J Hepatol; 2017 Oct; 67(4):862-873. PubMed ID: 28642059 [TBL] [Abstract][Full Text] [Related]
5. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A; J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and associated factors for non-alcoholic fatty liver disease among adults in the South Asian Region: a meta-analysis. Niriella MA; Ediriweera DS; Withanage MY; Darshika S; De Silva ST; Janaka de Silva H Lancet Reg Health Southeast Asia; 2023 Aug; 15():100220. PubMed ID: 37614359 [TBL] [Abstract][Full Text] [Related]
8. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? Amarapurkar DN; Hashimoto E; Lesmana LA; Sollano JD; Chen PJ; Goh KL; J Gastroenterol Hepatol; 2007 Jun; 22(6):788-93. PubMed ID: 17565631 [TBL] [Abstract][Full Text] [Related]
9. An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia. Hsu CS; Kao JH Expert Rev Gastroenterol Hepatol; 2017 Aug; 11(8):759-772. PubMed ID: 28613087 [TBL] [Abstract][Full Text] [Related]
10. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Li J; Zou B; Yeo YH; Feng Y; Xie X; Lee DH; Fujii H; Wu Y; Kam LY; Ji F; Li X; Chien N; Wei M; Ogawa E; Zhao C; Wu X; Stave CD; Henry L; Barnett S; Takahashi H; Furusyo N; Eguchi Y; Hsu YC; Lee TY; Ren W; Qin C; Jun DW; Toyoda H; Wong VW; Cheung R; Zhu Q; Nguyen MH Lancet Gastroenterol Hepatol; 2019 May; 4(5):389-398. PubMed ID: 30902670 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of influencing factors and causes of death in elderly residents with non-alcoholic fatty liver disease]. Xu JY; Shao Y; Lu XL; Deng J; Li XL; Shi HT Zhonghua Gan Zang Bing Za Zhi; 2019 Mar; 27(3):204-209. PubMed ID: 30929337 [No Abstract] [Full Text] [Related]
12. Epidemiology of non-alcoholic fatty liver disease. Bellentani S; Scaglioni F; Marino M; Bedogni G Dig Dis; 2010; 28(1):155-61. PubMed ID: 20460905 [TBL] [Abstract][Full Text] [Related]
13. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of non-alcoholic fatty liver disease: population based study. Amarapurkar D; Kamani P; Patel N; Gupte P; Kumar P; Agal S; Baijal R; Lala S; Chaudhary D; Deshpande A Ann Hepatol; 2007; 6(3):161-3. PubMed ID: 17786142 [TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. Streba LA; Vere CC; Rogoveanu I; Streba CT World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859 [TBL] [Abstract][Full Text] [Related]
16. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Vernon G; Baranova A; Younossi ZM Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852 [TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic Fatty Liver Disease: East Versus West. Agrawal S; Duseja AK J Clin Exp Hepatol; 2012 Jun; 2(2):122-34. PubMed ID: 25755421 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran. Mansour-Ghanaei F; Joukar F; Mobaraki SN; Mavaddati S; Hassanipour S; Sepehrimanesh M Diabetes Metab Syndr; 2019; 13(2):1591-1596. PubMed ID: 31336526 [TBL] [Abstract][Full Text] [Related]
19. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound. Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896 [TBL] [Abstract][Full Text] [Related]
20. The prevalence of nonalcoholic fatty liver disease in the Americas. López-Velázquez JA; Silva-Vidal KV; Ponciano-Rodríguez G; Chávez-Tapia NC; Arrese M; Uribe M; Méndez-Sánchez N Ann Hepatol; 2014; 13(2):166-78. PubMed ID: 24552858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]